Geron Corporation
GERN
$1.07
-$0.01-0.93%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/8/2025
-
MarketBeat
11/8/2025
-
MarketBeat
11/7/2025
-
MarketBeat
11/7/2025
-
MarketBeat
11/6/2025
-
MarketBeat
11/6/2025
-
Ticker Report
11/6/2025
-
MarketBeat
11/6/2025
-
Simply Wall St
11/5/2025
-
GuruFocus
11/5/2025
-
GuruFocus
11/5/2025
-
GuruFocus
11/5/2025
-
SeekingAlpha.com: All News
11/5/2025
-
SeekingAlpha
11/5/2025
-
Seeking Alpha: Transcripts
11/5/2025
-
Zacks Investment Research
11/5/2025
-
GuruFocus
11/5/2025
-
GuruFocus
11/5/2025
-
GuruFocus
11/5/2025
-
GuruFocus
11/5/2025
-
The Fly
11/5/2025
-
The Fly
11/5/2025
-
Business Wire
11/4/2025
-
Benzinga
11/4/2025
-
GuruFocus
11/4/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 473 7700
Address
919 East Hillsdale Boulevard
Foster City, CA 94404
Foster City, CA 94404
Country
Year Founded
Business Description
Sector
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f...
more